These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8150777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates in breast cancer: antitumor effects.
    Aft R.
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988
    [Abstract] [Full Text] [Related]

  • 4. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer.
    van Holten-Verzantvoort AT, Papapoulos SE.
    Medicina (B Aires); 1997 Apr; 57 Suppl 1():109-13. PubMed ID: 9567363
    [Abstract] [Full Text] [Related]

  • 5. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B, Simmons C, Broom R, Trinkaus M, Clemons M.
    Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
    [Abstract] [Full Text] [Related]

  • 6. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [Abstract] [Full Text] [Related]

  • 7. [Bisphosphonates and breast cancer].
    Vehmanen L, Saarto T.
    Duodecim; 2010 Dec; 126(10):1229-37. PubMed ID: 20597352
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Dec; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 9. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K, Katsouda E, Stathopoulou E, Vlahos L.
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [Abstract] [Full Text] [Related]

  • 10. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
    Clemons M, Dranitsaris G, Cole D, Gainford MC.
    Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806
    [Abstract] [Full Text] [Related]

  • 11. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.
    Liauw W, Segelov E, Lih A, Dunleavy R, Links M, Ward R.
    BMC Cancer; 2005 Jul 28; 5():89. PubMed ID: 16048654
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates: clinical experience.
    Coleman RE.
    Oncologist; 2004 Jul 28; 9 Suppl 4():14-27. PubMed ID: 15459426
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R, Olson K, Van Poznak C.
    Hematol Oncol Clin North Am; 2007 Apr 28; 21(2):341-67. PubMed ID: 17512453
    [Abstract] [Full Text] [Related]

  • 14. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D, Plestina S, Belev B, Unusić J, Pavlinić-Diminić V.
    Lijec Vjesn; 1999 Apr 28; 121(9-10):296-301. PubMed ID: 19658372
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonate therapy for patients with breast carcinoma.
    Plunkett TA, Rubens RD.
    Cancer; 2003 Feb 01; 97(3 Suppl):854-8. PubMed ID: 12548586
    [Abstract] [Full Text] [Related]

  • 16. New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
    Rosen LS.
    Oncology (Williston Park); 2004 May 01; 18(5 Suppl 3):26-32. PubMed ID: 15202585
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul 01; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 18. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E, Kumpulainen E.
    Duodecim; 1999 Jul 01; 115(1):27-32. PubMed ID: 11830857
    [No Abstract] [Full Text] [Related]

  • 19. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R.
    Breast; 2007 Dec 01; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ.
    Can J Oncol; 1995 Dec 01; 5 Suppl 1():16-27. PubMed ID: 8853520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.